Image via Wikipedia
SCIENTISTS HAVE taken another important step towards producing replacement tissues for the body using stem cells. A group in Germany has developed a simpler way to produce these cells using just one special factor instead of the usual four.
The work helps build knowledge of how to produce the most powerful or “pluripotent” stem cells but new treatments using them are still some distance into the future, according to stem cell specialist Dr Stephen Sullivan.
Prof Hans Schöler led the work at the Max Planck Institute for Molecular Biomedicine and details are published this morning online by the journal
Mesenchymal stem cells are present in placental blood and could represent the new frontier for tissue and organ regeneration. The cells were identified at the cell factory at Milan’s Policlinico Hospital and will be the subject of a meeting on mesenchymal stem cells organized by the Milan hospital.
Isolated and preserved in the Milan biobank for the first time for use in future treatments, the cells come from blood that is collected at birth. Plasma that has been used for transplants in patients with serious diseases like leukemia and lymphoma and represent a potential reserve of mesenchymal stem
Image via Wikipedia
Summit at Lake Como with 100 European stem cell experts.
At the summit, 16 research teams part of the Neurostemcell consortium that have been working for months on finding treatments for Parkinson’s and Huntington’s disease met. The network, coordinated by Elena Cattaneo, Director of Unistem, the interdepartmental stem cell research centre of the University of Milan, met on April 1 in Bellagio, on the shores of Lake Como for their first annual meeting.
“The meeting is an opportunity to discuss the results obtained until now and to refine our methods,” explained Cattaneo, who pointed out the objective of
The California Institute for Regenerative Medicine (CIRM) and the Chinese Ministry of Science and Technology (MOST) have agreed to collaborate on stem cell research. The agreement will make it easier to form cross-border teams that are working in similar areas. If the teams’ funding requests are approved, the researchers in each country will be supported by their respective agency, CIRM or MOST. The formal announcement, made today, adds details to a story that ChinaBio® Today originally broke late last week (…)
“Our collaboration will benefit patients in our countries and patients around the globe,” said Wan Gang, Minister, MOST. “We
Image by Associazione Luca Coscioni via Flickr
“What I cannot stand, what really gets me, is that we have set up a scam, in which Italy says that for moral reasons it is against embryonic stem cell research, but then it reaps the benefits from the research: if Italy is truly against stem cell research, the government must say that Italian citizens will never benefit from the discoveries that will come from the research”, said Italian researcher Elena Cattaneo, who spoke at the 2nd World Congress for “freedom of research’ of the Luca Conscioni Association in Brussels.
At the congress, 1993